|
|
Role of Mitophagy in Cardiovascular Disease
|
Yang Yibo, Li Tianyi, Li Zhibo, Liu Ning, Yan Youyou, Liu Bin
|
|
|
Table1 Therapeutic application of mitophagy. |
|
Diseases | Representatives | Mechanisms | Effects | References |
---|
MicroRNAs | I/R | MiR-410 | Mitophagy- | damage | [165] | I/R | MiR-137 | BNIP3/FUNDC1- | - | [166] | Cardiac Lipotoxicity, DCM | MiR-133a | Nix- | protection | [167] |
| Clinical drugs and chemical reagents |
| I/R | Melatonin | PINK1/Parkin- | protection | [168] | DCM | Melatonin | PINK1/Parkin+ | protection | [169] | AS | Melatonin | PINK1/Parkin+ | protection | [170] | I/R | Simvastatin | Parkin/P62+ | protection | [171] | I/R | Liraglutide | Parkin+ | protection | [172] | I/R | Zine | PINK1+ | protection | [173] | I/R | Sevoflurane postconditioning | Parkin- | protection | [174] | I/R | TEMPOL preconditioning | PINK1/Parkin+ | protection | [175] | HF | Curcumin | BNIP3- | protection | [176] | Cardiotoxicity | Ellagic acid | BNIP3- | protection | [177] | Stroke | Tunicamycin and thapsigargin | Mitophagy+ | protection | [178] | Stroke | Peroxynitrite | PINK1/Parkin+ | damage | [179] | Stroke | Naringin | Parkin- | protection | [180] |
| Signal pathways |
| AS | NR4A1/CaMKII activation | Parkin+ | damage | [145] | Stroke | MAPK-ERK-CREB blockade | Mfn2- | damage | [181] | I/R | Rab5 endosomal pathway activation | Parkin+ | protection | [182]. | I/R | P53/TIGAR activation | BNIP3- | damage | [183] | HF | JNK/FOXO3a activation | BNIP3+ | damage | [184]. |
| Activators/inhibitors, genes knock in/out |
| I/R | STAT1 activation | Mitophagy- | damage | [185] | AS | PINK1/Parkin knockout | PINK1/Parkin- | damage | [146, 147] | I/R | GPER activation | PINK1/Parkin- | protection | [93] | I/R | ALDH2 activation | PINK1/Parkin- | protection | [186] | DCM | Sirt3 overexpression | Parkin+ | protection | [187] | DCM | Mst1 knockout | Parkin+ | protection | [188] | HF | BAG3 knockdown | Parkin- | damage | [189] | AS | F13A | PINK1/Parkin- | protection | [190] | HF | CsA | PINK1/Parkin- | protection | [191] | HF | Akt2 knockout | BNIP3/PINK1/Parkin+ | protection | [192] | Stroke | Nix knockout | Nix- | damage | [161] | I/R | DUSP1 activation | BNIP3- | protection | [98] | HF | SWI/SNF deletion | BNIP3+ | damage | [193] | I/R | FUNDC1 knockout | FUNDC1- | damage | [96] |
| Environmental stimuli |
| I/R | Mild hypothermia | Parkin- | protection | [194] | I/R | Hypoxic preconditioning | FUNDC1+ | protection | [96] | Myocardial inflammatory | Acute exercise | BNIP3+ | protection | [80] | I/R | Exercise preconditioning | Parkin+ | protection | [195] | Stroke | Acidic postconditioning | Mitophagy+ | protection | [196] | Stroke | Remote ischemic post conditioning | Parkin+ | protection | [197] |
|
|
|